Millennium Management
LEGN icon

Millennium Management’s Legend Biotech LEGN Stock Holding History

Millennium Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-284,911
Closed -$5.15M – 6167
2026
Q1 		$5.15M Buy
284,911
+207,717
+269% +$3.96M ﹤0.01% 2903
2025
Q4 		$1.68M Sell
77,194
-715,291
-90% -$20.5M ﹤0.01% 4093
2025
Q3 		$25.8M Buy
792,485
+51,638
+7% +$1.91M 0.01% 1389
2025
Q2 		$26.3M Sell
740,847
-117,642
-14% -$3.81M 0.01% 1321
2025
Q1 		$29.1M Buy
858,489
+603,021
+236% +$21.6M 0.02% 1175
2024
Q4 		$8.31M Sell
255,468
-314,908
-55% -$13M ﹤0.01% 2356
2024
Q3 		$27.8M Sell
570,376
-1,088,305
-66% -$58M 0.01% 1260
2024
Q2 		$73.5M Buy
1,658,681
+1,287,590
+347% +$59.4M 0.03% 573
2024
Q1 		$20.8M Sell
371,091
-211,059
-36% -$12.7M 0.01% 1524
2023
Q4 		$35M Buy
582,150
+556,342
+2,156% +$35.3M 0.02% 1070
2023
Q3 		$1.73M Sell
25,808
-245,748
-90% -$17.1M ﹤0.01% 3694
2023
Q2 		$18.7M Sell
271,556
-270,446
-50% -$17.7M 0.01% 1453
2023
Q1 		$26.1M Buy
542,002
+181,885
+51% +$8.9M 0.02% 1146
2022
Q4 		$18M Sell
360,117
-327,581
-48% -$15.9M 0.01% 1542
2022
Q3 		$28.1M Buy
687,698
+444,096
+182% +$20.8M 0.02% 1054
2022
Q2 		$13.4M Sell
243,602
-322,322
-57% -$13.6M 0.01% 1704
2022
Q1 		$20.6M Buy
565,924
+413,890
+272% +$16.4M 0.01% 1365
2021
Q4 		$7.09M Buy
152,034
+1,327
+0.9% +$67.3K ﹤0.01% 2538
2021
Q3 		$7.62M Buy
150,707
+92,867
+161% +$3.86M ﹤0.01% 2392
2021
Q2 		$2.37M Buy
57,840
+40,666
+237% +$1.38M ﹤0.01% 3756
2021
Q1 		$498K Buy
+17,174
New +$468K ﹤0.01% 4831
2020
Q4 		– Sell
-130,802
Closed -$4.04M – 5412
2020
Q3 		$4.04M Sell
130,802
-150,444
-53% -$5.07M 0.01% 2033
2020
Q2 		$12M Buy
+281,246
New +$11M 0.02% 1092

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Millennium Management's LEGN Position: Q2 2026 in Review

Millennium Management sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 284,911 shares — an estimated $5.15M sold.

Millennium Management first reported a position in LEGN in Q2 2020 and held it in 23 quarters. The position peaked at $73.5M in Q2 2024. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Millennium Management reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Millennium Management sold 284,911 Legend Biotech shares in Q2 2026, an estimated $5.15M.
  • Millennium Management first reported a position in Legend Biotech in Q2 2020 and held it in 23 quarters.
  • Millennium Management's Legend Biotech position peaked at $73.5M in Q2 2024.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.